EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study

Antoine Braud, Pierre Auloge, Nicolas Meyer, Caroline Bouvrais, Mousselim Gharbi, Hervé Lang, Afshin Gangi, Dan Lipsker

CardioVascular and Interventional Radiology · 2024-05 · 47 (5) · 567-572

DOI: 10.1007/s00270-024-03699-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, online erschienen am 03.04.2024. Verfasst von Antoine Braud und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologic Clinic, University Hospital of Strasbourg, Strasbourg, France. antoine.braud@chru-strasbourg.fr. Hauptthemen laut MEDLINE: Melanoma, Neoadjuvant Therapy, Cryosurgery, Proof of Concept Study. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: Bristol-Myers Squibb.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaNeoadjuvant TherapyCryosurgeryProof of Concept StudyLymphatic MetastasisIpilimumabSkin NeoplasmsNivolumabHumansMaleFemaleMiddle AgedAgedImmunotherapyNeoplasm StagingLymph Node ExcisionAdultFeasibility StudiesAntineoplastic Agents, ImmunologicalTomography, X-Ray ComputedTreatment OutcomeCombined Modality Therapy

Stichwörter der Autor:innen

ImmunotherapyMelanomaNeoadjuvantPercutaneous cryoablationStage III

Substanzen

IpilimumabNivolumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Dermatologic Clinic, University Hospital of Strasbourg, Strasbourg, France. antoine.braud@chru-strasbourg.fr.
  • Interventional Radiology, University Hospital of Strasbourg, Strasbourg, France.
  • Public Health Department, University Hospital of Strasbourg, Strasbourg, France.
  • Direction de la Recherche Clinique et de l'innovation (DRCI), University Hospital of Strasbourg, Strasbourg, France.
  • Department of Gynecology, University Hospital of Strasbourg, Strasbourg, France.
  • Departments of Urology, University Hospital of Strasbourg, Strasbourg, France.

Förderung

  • Bristol-Myers Squibb

Zitieren

APA

Braud, A., Auloge, P., Meyer, N., Bouvrais, C., Gharbi, M., Lang, H., Gangi, A., & Lipsker, D. (2024). Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study. CardioVascular and Interventional Radiology, 47(5), 567-572. https://doi.org/10.1007/s00270-024-03699-9

Vancouver

Braud A, Auloge P, Meyer N, Bouvrais C, Gharbi M, Lang H, et al. Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study. CardioVascular and Interventional Radiology. 2024;47(5):567-572. doi:10.1007/s00270-024-03699-9

BibTeX
@article{Braud2024,
  author = {Braud, Antoine and Auloge, Pierre and Meyer, Nicolas and Bouvrais, Caroline and Gharbi, Mousselim and Lang, Hervé and Gangi, Afshin and Lipsker, Dan},
  title = {Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study},
  journal = {CardioVascular and Interventional Radiology},
  year = {2024},
  volume = {47},
  number = {5},
  pages = {567--572},
  doi = {10.1007/s00270-024-03699-9}
}
Kostenlos starten →